Pehlivan M

Pehlivan M

Gaziantep University - Gaziantep / Türkiye
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4349845
Gaziantep Üniversitesi
person_outline Pehlivan M's MOST POPULAR ARTICLES
1-) Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label … The Lancet Oncology 20 (6), 781-794, 2019
2-) Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 … The Lancet Oncology 22 (6), 801-812, 2021
3-) Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group‐Sarcoma Working Party American journal of hematology 83 (9), 702-707, 2008
4-) TNF-alpha, TGF-beta, IL-10, IL-6 and IFN-gamma gene polymorphisms as risk factors for brucellosis New Microbiol 32 (2), 173-8, 2009
5-) TNF-alpha, TGF-beta, IL-10, IL-6 and IFN-gamma gene polymorphisms as risk factors for brucellosisI Karaoglan, S Pehlivan, M Namiduru, M Pehlivan, C Kilinçarslan, ...New Microbiol 32 (2), 173-8, 2009732009